NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Non Small Cell Lung Cancer
Both
Non Small Cell Lung Cancer
Trial Information
NM404 as an Imaging Agent in Patients With Non-small Cell Lung Cancer (NSCLC)
Inclusion Criteria:
Part 3- Histologically or cytologically documented NSCLC with measurable of disease
- Disease is evaluable by CT scan
- At least 18 years old. Women cannot be pregnant or breastfeeding
- Karnofsky score >/= to 60
- Adequate renal/hepatic function
- Adequate blood cell count levels
Exclusion Criteria:
- Concomitant infection
- Other active cancers
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Outcome Measure:
Imaging characteristics
Outcome Time Frame:
5 days
Safety Issue:
No
Principal Investigator
Anne M Traynor, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
University of Wisconsin, Madison
Authority:
United States: Food and Drug Administration
Study ID:
H-2002-582
NCT ID:
NCT00582283
Start Date:
January 2004
Completion Date:
June 2014
Related Keywords:
- Non Small Cell Lung Cancer
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
Name | Location |
|---|---|
| University of Wisconsin Carbone Comprehensive Cancer Center | Madison, Wisconsin 53792 |
